Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof
US11919964B2 · kind B2 · utility
0Cited by
19References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2020 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | Sep 22, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to bispecific antigen binding proteins that are capable of binding to both the human CGRP receptor and the human PAC1 receptor. Pharmaceutical compositions comprising the bispecific antigen binding proteins as well as methods for producing them are also disclosed. Methods of using the bispecific antigen binding proteins to ameliorate or treat conditions associated with the two receptors, such as chronic pain, migraine, and cluster headache, are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.